Samsung Electronics Health and Medical Equipment Business and Samsung Medison participated in the 2024 Radiological Society of North America (RSNA) conference in Chicago, United States, from December 1st to 5th (local time) and unveiling an even more diverse product lineup.

To strengthen its competitiveness across medical specialties, after the launch of a new OB & GYN ultrasound diagnostic system, HERA Z20, Samsung proposed ‘pediatric integrated solution’ encompassing the entire range of its medical diagnostic devices through this RSNA.

In the ‘Ultrasound Zone,’ a dedicated probe for the pediatric cardiac diagnosis ‘TA2-9’ was unveiled for the first time at this exhibition. The TA2-9 with 42% smaller head than adult echocardiography probe aids in more accurate diagnosis for congenital heart disease or functional and structural abnormalities of heart through the oral route. Also on display was ‘L3-22’, a dedicated neonatal probe featuring a smaller head compared to an adult version offering a wide frequency range which enables pediatric body scan with a single device without the need to switch probes.

All US Food and Drug Administration (FDA) 510(k) cleared products of Samsung digital X-ray have ‘low dose’ capability making it more appropriate for diagnosis of children and adolescents where safety is particularly prioritized. Samsung’s proprietary S-Vue imaging engine reduces radiation exposure by up to 50% compared to systems without this technology.

At this exhibition, Samsung launched a new ‘floor-mounted’ digital X-ray, GF 85. The new digital X-ray, GF 85 launched by Samsung is relatively affordable compared to ceiling-mounted type and cost-effective with the ability to be installed in a small space without ceiling construction. Moreover, it provides clear image quality even with low dose and is equipped with advanced AI diagnostic assistance feature, fully inheriting all the advantages of previous digital X-ray models.

NeuroLogica Corp, a subsidiary of Samsung Electronics, includes the OmniTom Elite mobile computed tomography (CT) in its portfolio, useful for imaging pediatric patients and at point-of-care, facilitating rapid clinical decision making and reducing transport related risks. Mobile CT is already recognized for its utility, with 8 out of the top 10 U.S. pediatric hospitals (as ranked by U.S. News for 2024-2025) utilizing the technology.

NeuroLogica’s OmniTom Elite with photon counting detector (PCD) technology showcased this year’s at RSNA delivers ultra high-resolution CT imaging at the point-of-care using FDA 510(k) cleared PCD technology, surpassing conventional CT methods that rely on energy integrating detectors. By utilizing photon counting detectors to measure the energy of each individual photon, this cutting-edge technology enhances contrast differentiation and virtual monoenergetic imaging, empowering radiologists with greater confidence in diagnosing patients.

Samsung provides opportunity to gain clinical application tips of Samsung medical devices and engage in Q&A with the global experts through Lunch & Learn session. In this session, a global breast imaging expert, Dr. Nina Vincoff shared a screening program using Samsung breast ultrasound solution and the latest insights on the FDA’s mandate for breast density information provision and implementation of additional imaging examination recommendation for dense breast (effective on September 10, 2024).

Dr. Farhad Farzanegan in Kasier Permanente South Sacramento health system U.S. presented a case study on hospital workflow improvement based on the result of CT intervention procedure using Samsung mobile full-body CT, BodyTom.

In the booth, Dr. Jon Jacobson, a musculoskeletal radiology expert, conducted live scan using a premium ultrasound diagnostic device, RS85 Prestige introducing clearer image quality and more sophisticated AI diagnostic assistance feature.

The leader of the Samsung Medison AI&Informatics group, Vijay, said “I discovered a greater potential through high praises from medical professors around the world who visited the site” and “Moving forward, we aim to further enhance our AI diagnostic support features tailored to specialized medical fields, solidify our technological leadership in radiology and obstetrics, and expand our competitiveness across all medical disciplines to pioneer new markets.”

▲ The HERA W10 Elite features an ergonomic-friendly design and is optimized with updated imaging capabilities to drive diagnostic confidence.

Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, introduces the HERA W10 Elite,¹ the premier model of the HERA platform for Obstetrics and Gynecology that provides clinicians with a suite of powerful artificial intelligence (AI) tools and clinical applications to advance the diagnostic experience.

“Women’s health is a fast-growing field that requires state-of-the-art equipment for patient care. The HERA W10 Elite will bring visionary change to Obstetrics and Gynecology with sophisticated image processing and an ergonomic-friendly design,” said Tracy Bury, Women’s Health Ultrasound Business Leader, Boston Imaging.

The HERA W10 Elite may assist clinicians in receiving greater insight in diagnosis with its intuitive visualizations, precise analytic features and fast operation. The revolutionized system has also been updated from its predecessor in a variety of aspects, including:

• Advanced MV-Flow: To display the intensity of blood flow, it provides 2D and 3D visualization of microcirculatory and slow blood.
• Larger OLED Display: The display area has been increased by 57%,² while the OLED³ screen realistically represents black colors making it well-suited for diverse ultrasound image characteristics.
• New Transducer: The EV2-12⁴ allows visualization of the fetal heart and brain starting at eight weeks endovaginally.

The system is also equipped with enhanced AI features, such as:

• HeartAssist: Provides measurement results and automatically classifies an ultrasound image into measurement views required for fetal heart diagnosis.
• ViewAssist: Automatically classifies ultrasound images and annotates the structures for convenient measurement (16 new views added). ^4,5
• BiometryAssist: Enables clinicians to measure fetal growth parameters with a single click while maintaining exam consistency.⁴

Samsung is committed to bringing new and updated women’s health-focused ultrasound systems to market to remain true to its pledge to support the life-long healthcare of women. The HERA W10 Elite will be showcased at the Society for Maternal Fetal Medicine’s 43rd Annual Pregnancy Meeting from February 8 to 10 at booth #317.

Additional information on the system can be found here.

About Boston Imaging

Boston Imaging markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Boston Imaging is the United States headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Boston Imaging’s growing portfolio of advanced medical technologies is used in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction and increase workflow efficiency. For more information, please visit https://www.bostonimaging.com/.

¹ Elite is not a product name but is a marketing terminology.

² Compared to Samsung HERA W10

³ OLED: Organic Light-Emitting Diode

⁴ The hardware and software features are FDA 510(k) pending, not available for sale in United States.

⁵ ViewAssist fully covers global guidelines from 1st to 3rd trimester.

During this congress, Samsung will be showcasing the clinical values and efficiencies of the Artificial Intelligence (AI)-based diagnostic solutions through various scientific programs.

Samsung’s symposium will be held on September 18^th at 12:35 p.m. This event will also run online under the theme of “Samsung’s Advanced AI and Remote Diagnosis Solutions.” Prof. Julien Stirnemann (Necker Hospital, France) will deliver research results on the clinical values of two AI diagnostic solutions: BiometryAssist which measures the growth and condition of a fetus and HeartAssist which improves workflow when diagnosing a fetal heart.

Professor Antonia Testa (Scientific Director of the Center for Ultrasound in Gynecological Oncology “Class Ultrasound” of the Agostino Gemelli University Hospital, Rome, Italy) will be demonstrating her experience with SonoSync, a real-time ultrasound image-sharing solution during Samsung’s Symposium. She will be presenting the simplicity and benefits of image sharing as a second opinion by remotely accessing a HERA W10 system at Gemelli Hospital, Rome from the ISUOG venue in London.

“This will be a live demonstration of a patient scan, voice communication with a sonographer, and remote measurements executed in London. This advancement in ultrasound environment using SonoSync brings telesonography into reality,” said Professor Antonia Testa. “I believe Samsung’s forward-thinking technologies and advanced developments in ultrasound in recent years are quite impressive.”

In addition, Samsung will be hosting four onsite Hospitality Suite programs with lectures and live demonstrations for customers to experience high performance diagnostic solutions such as MV-Flow which is used to visualize the slow flow of microvascular structures and the existence of micro-blood-flow.

The onsite scientific programs, Samsung will display online webinars at six times during the congress through ISUOG’s virtual platform. More details on Samsung’s scientific programs can be found on the ISUOG website and the Samsung’s Healthcare website (www.samsunghealthcare.com).

Samsung will also showcase its premium ultrasound system for obstetrics and gynecology known as HERA W10 and V8 which systems includes Intelligent Assist (AI diagnostic solutions), as well as V7, high-end ultrasound systems that can be used in various medical specialties and also with premium AI diagnostic solutions.

As far as the name, the “V” in “V7” stands for “Versatile,” meaning that this system can be used in various medical fields such as obstetrics, gynecology, radiology, orthopedics, cardiology and more. The V7 hosts features and solutions seen on premium ultrasound systems.

※ The diagnostic solutions provided with V8 and V7 are the same, but there are some differences in their image resolution.

Kyu Tae Yoo, Senior Vice President, Head of Sales & Marketing Team of Samsung Medison stated “This is a very meaningful time for us as we share the clinical values of our ultrasound AI-based diagnostic tools and features in collaboration with so many prominent medical professionals. We will continuously proceed forward introducing diagnostic solutions for the medical professionals and patients.”

For more information on Samsung’s Healthcare division, its subsidiaries and products please visit https://www.samsunghealthcare.com.

Exhibition products at ISUOG 2022 (from left — V7, HERA W10, V8)

SonoSync — Solution to overcome spatial constraints when performing ultrasound exams

About Samsung Medison

Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

* Content has been updated as of February 10, 2023 to more accurately reflect product information.

“Since the launch of the ‘Intelligent Assist’ solution in 2020, we have been actively listening to the needs of our customers and have reflected the needs of the market into our enhanced AI-based image processing technologies and diagnostic assistance functions,” said Won-Chul Bang, Vice President, Head of Customer Experience Team at Samsung Medison. “We will actively introduce various ultrasound diagnosis solutions to meet customers’ needs in the future preemptively.”

Samsung is launching its enhanced ‘Intelligent Assist’ software in its premium ultrasound device, HERA W10, and will be presenting its clinical values for “Improving Accuracy and Efficiency” for fetal anomaly detection using its AI solutions during the online symposium on October 17^th.

‘Intelligent Assist’ solution includes ‘Biometry Solution’ for assessment of the fetal growth and ‘Fetal Heart Solution’ for the assessment of the fetal heart.

‘Biometry Solution’ recognizes images such as the fetal head, abdomen, lower extremities and others and measures the fetal growth and development while the ‘Fetal Heart Solution’ recognizes the view of the fetal heart, annotates the images and measures the necessary fetal heart structures for a thorough fetal heart anomaly assessments.

During the symposium, Aris Papageorghiou, Clinical Research Director of the Maternal and Perinatal Health Institute at Oxford UK and the professor in obstetrics and fetal medicine at St George’s University Hospitals UK, will be introducing his clinical experiences with Samsung’s ‘Intelligent Assist’ solutions.

Hye-Sung Won, professor of the Department of Obstetrics and Gynecology at Asan Medical Center, Korea, will introduce the MPI+ that semi-automatically measure LV MPI and RV MPI to analyze the fetal heart function. She will also be presenting her findings of the feasibility and reliability of ‘Fetal Heart Solution’ in automatically providing complex fetal heart view image classifications and fetal heart structural measurements.

In addition, Samsung will be introducing its high-end versatile ultrasound device ‘V8’, first released on September 30^th, at the virtual exhibition hall during ISUOG 2021.

‘V8’ will include some of the enhanced solutions that are dedicated to the premium ultrasound system such as MV-Flow, a novel alternative to power Doppler for visualizing the slow flow of micro-vascularized structures, and LumiFlow, three-dimensional visualization of blood flow which helps the user understand the structure of small vessels intuitively. ‘V8’ will also include some of the ‘Intelligent Assist’ solutions to cater to the needs of the larger busy hospitals.

For more information on Samsung’s healthcare division, its subsidiaries and products, please visit https://www.samsunghealthcare.com.

The image delineates that the fetal head is automatically recognized and measured along with the fetal growth when ‘Biometry Solution’ is executed.

The feature automatically recognizes and annotates the anatomy of the fetal heart and displays measured values when the ‘Fetal Heart Solution’ is executed.

About Samsung Medison
Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

“It’s very meaningful to launch the V8, a new premium medical device that addresses many customer needs,” said Won-Chul Bang, Vice President, Head of Customer Experience Team, Samsung Medison. “We expect V8 to become a flagship product of premium ultrasound systems as it is uniquely designed to cover different medical specialties.”

V8’s “V” stands for “Versatile,” meaning that the advanced functions from premium ultrasound systems dedicated to specific departments such as obstetrics, radiology, orthopedics and cardiology have been implemented.

Several diagnostic assistance functions of a premium ultrasound system for obstetrics and gynecology include MV-Flow which is suitable for observing the presence of microvascular blood flow, low-velocity blood flow and LumiFlow which provides three-dimensional visualization of blood flow in a two-dimensional image, allowing the medical staff a more realistic assessment of the vascular structures and flow.

For radiology, V8 is equipped with S-Shearwave Imaging which provides information about tissue stiffness as a result of disease using ultrasonic transverse elasticity. V8 also features S-Fusion which allows synchronous alignment of medical images of ultrasound with one or more cross-sectional studies such as MRI which are instantly reconstructed in the corresponding plane.

On the other hand, it is also expected to be equipped with a NerveTrack which has been cleared by the U.S. Food and Drug Administration (FDA) as an AI medical device and can be used to treat musculoskeletal diseases that track nerve locations in pain areas in real time.

In addition, by introducing a 23.8″ LED monitor and a 14″ high-sensitivity touch panel, user convenience has been enhanced to perform various procedures.

The screen that automatically tracks the nerve’s location on the wrist in real time with the NerveTrack function is executed.

About Samsung Medison

Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

* Content has been updated as of February 10, 2023 to more accurately reflect product information.

Samsung Electronics is showcasing the latest diagnostic imaging medical equipment and AI-based solutions at ECR 2019 – European Congress of Radiology in Vienna, Austria. At booth #406 (Expo. X4), Samsung is displaying a variety of diagnostic imaging equipment, especially, the X-ray zone, which was designed and inspired by pediatric wards, features a new low dose imaging processing engine for children.

“We are pleased that Samsung’s AI technologies have been successfully applied to the existing diagnostic imaging devices and have been well received in the market,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “Samsung will continue to deliver on our promise of fast, easy and accurate diagnostic solutions for our customers in the healthcare community.”

Samsung is continuing to expand its boundaries in finding new solutions in radiology ultrasound. At ECR 2019, Samsung will introduce its solutions for breast screening and real-time streaming solutions in ultrasound including:

■ Breast Screening Solutions

• S-Detect for Breast is an AI-based software which analyzes breast lesions using ultrasound images. It assists in standardizing reports and classification of suspicious breast lesions by incorporating BI-RADS® ATLAS (Breast Imaging-Reporting and Data System, Atlas) into the tool. When the user selects a region of interest, S-Detect for Breast analyzes the selected lesion and provides lexicon classification options with a streamlined workflow.

• S-Shearwave Imaging allows for non-invasive measurement of the stiffness of tissue/lesions in the breast, by providing an advanced level of diagnostic information. The color-coded elastogram, quantitative measurements (in kPa or m/s) are especially useful to healthcare professionals for making an accurate diagnosis of breast diseases. The reliability of the result is highly improved by providing the RMI (Reliable Measurement Index)

• MV-Flow offers a novel alternative to Color Doppler for visualizing slow flow microvascularized structures. High frame rates and advanced filtering enable MV-Flow to provide a detailed view of blood flow in relation to surrounding tissue or pathology of suspicious breast lesions.

• ElastoScan+ is an ultrasound technology for imaging elasticity. It detects the presence of solid breast masses in tissues and converts any stiffness into color images. Samsung provides semi-quantification assessment designed to enable quick and easy calculation of the strain ratio.

■ Real-time Ultrasound Image Sharing Solution

• SonoSync provides a real-time streaming network service that overcomes the spatial limitations of conventional ultrasound exam operations. Compared with general video sharing solutions, it also has the advantage of supporting bidirectional communication such as voice chat and marking.With SonoSync, clinicians on both sides can simultaneously review the shared images and have discussions during the examination. SonoSync can be simply used without any additional hardware for ultrasound scanners and can be easily connected with various devices such as smartphones, tablets, laptops, and desktop PCs.

Samsung recently announced that the U.S. Food and Drug Administration (FDA) has approved pediatric low dose across its entire digital X-ray portfolio.

“We are excited to expand our commitment on patient safety with the addition of U.S. FDA clearance for pediatric low dose that may improve dose care without compromise to image quality,” said Insuk Song, Senior Vice President of Health & Medical Equipment Business at Samsung Electronics. “Samsung is constantly working on pediatric-centric innovation to uphold ALARA (As Low As Reasonably Achievable) principle for minimizing radiation dose. Our dedication to pediatric care conveys the effort keep the long-term safety of children who are more sensitive to radiation and its cumulative effect.”

■ Dose Less Care More: From The Very Start

• S-Vue delivers high-resolution images through advanced processing technology. Especially, spatially adaptive multi-scale processing and advanced de-noising technology preserve the image quality at high standards despite the reduced dose of radiation. The advanced noise reduction algorithm in the S-Vue imaging processing engine cuts dosage by 45% to a low dose level for pediatric abdomen exams without sacrificing image quality¹.

Without worries of additional settings or exposure, you can easily improve the clarity of the clinical images to boost your diagnostic confidence empowered by Samsung’s unique post-processing feature, SimGrid.

• SimGrid allows you to provide better patient care with higher satisfaction and reduced retake rates without the use of a portable grid. It improves image contrast by reducing scatter radiation effects and creates better image quality.

Samsung is also presenting the mobile CT OmniTom^® and a prototype of Extremity MRI using Media Wall.

At the AI room of the event, visitors can learn about Samsung’s AI technology more easily. Samsung will also host a satellite symposium that will present clinical research using Samsung’s contrast-enhanced ultrasound technology and Pediatric DR Imaging for Patient Safety.

For more information on Samsung’s healthcare division, its subsidiaries and products, please visit https://www.samsunghealthcare.com.

¹ FDA 510(k) clearance: The non-clinical and clinical image evaluations show that the proposed devices with the new IPE (Image Post-processing Engine) employing and advanced noise reduction algorithm are able to reduce x-ray dose up to 47.5% for abdominal radiographs of average adult and up to 45% for pediatric abdomen, 15.5% for pediatric chest, and up to 27% for pediatric skull exams, compared with radiation doses needed to obtain similar image quality using the old IPE on the same x-ray systems.

At booth #506 (Expo. X5), Samsung is displaying medical equipment based on its ‘AccE’ (Access, Accuracy and Efficiency) strategy, which aims to change the industry by incorporating innovations in physical access to provide care wherever needed. Samsung also seeks to improve accuracy in diagnosis with advanced algorithms and efficiency with advanced display, UX and information management technology developed by Samsung Electronics.

“Samsung is committed to medical advancements for both diagnostic solutions and patient care. We will continue to develop optimized medical equipment to healthcare providers by combining our key values in the pursuit of Access, Accuracy and Efficiency,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison.

Within ultrasound systems, Samsung has made great achievements in Obstetrics and Gynecology and will continue to expand its portfolio to the radiology segment. At ECR 2018, Samsung will present upgraded ultrasound systems including:

• RS85, Samsung’s advanced premium ultrasound system for radiology that provides enhanced image quality and convenience for medical and radiology professionals. The RS85 features MV-Flow technology, which detects blood flow in the microvascular, and S-Shearwave Imaging, which provides new indicators for clinical diagnosis by quantifying the elasticity of tissue. The S-Fusion function extends analysis from the abdomen to the prostate, and also allows coordination and simultaneous comparative analysis of images from other modalities such as MRI and CT for easy and fast biopsy.

• HS70A with Prime, the high-end ultrasound system specifically designed to fit into a general ultrasound imaging setting from routine to complex. It features Arterial Analysis, which detects changes in vessels, providing measurement values such as stiffness. The S-Shearwave and Realistic Vue are additional features that improve image quality.

Samsung will also introduce digital radiography solutions that manage the dose for patients and meet the needs of healthcare providers, including:

• GC85A, which provides outstanding images that boost diagnostic confidence equipped with technologies such as S-Detector and S-Align. The device adopts Low Dose technology for enhanced patient safety. Samsung recently cleared in the U.S. FDA for 50% dose reduction in adults’ chest exams, using GC85A with the new imaging engine S-Vue3.02.

• GM85, a lighter version of original GM85 will be displayed. The weight is reduced, but the functional benefits such as enhanced mobility and streamlined workflow are still retained. GM85 provides advanced patient care through leading edge imaging functions.

At the Beyond Experience Zone, visitors can learn about Samsung’s efforts in supporting radiologists in their diagnoses through various software technologies such as SimGrid^TM, Bone Suppression and Dose Reduction. In addition to superb medical equipment, healthcare providers can visit the Low Dose Campaign Zone and experience how low the radiation dose of GC85A is compared to real life radiation through the Low Dose Quiz.

Samsung Electronics’ subsidiary NeuroLogica will showcase innovative mobile CT OmniTom^®, which features an array of improvements from Samsung’s award-winning CereTom^® CT scanner. OmniTom^® is ideal for cranial procedures and is designed to deliver high-quality non-contrast CT, CT angiography and CT perfusion scans. The combination of its rapid scan time, ultra-small footprint and immediate image viewing makes OmniTom^® an indispensable tool for collecting real-time data on critically ill patients. Samsung will also show its spectral CT with Photon Counting Detector (PCD), the next generation of CT technology.

Samsung is also presenting a prototype of Extremity MRI, which is expected to be a game changer in the industry. It is designed to improve not only cost and space efficiency but also patient convenience, as it reduces the need for the whole body to be in the MRI device to scan extremity areas such as arms and legs.

In addition to showcasing its portfolio of comprehensive healthcare solutions, Samsung will be hosting two satellite symposia throughout the week at ECR. Samsung’s symposia will highlight the key trends and issues across ultrasound imaging and digital radiography technologies.

For more information on Samsung’s healthcare division, its subsidiaries and products, please visit https://www.samsunghealthcare.com/.

The release of OmniTom^® is the latest demonstration of Samsung’s leadership in CT imaging. OmniTom^® features an array of improvements from Samsung’s award-winning CereTom CT scanner, including:

• Improved workflow: OmniTom^® is the world’s first mobile imaging device with omni-directional wheels, maximizing mobility and allowing easier and quieter movement in small spaces.
• Superior image quality: 16-slice (0.625 mm per slice) advanced data acquisition system with a 50 percent increase in CNR versus other portable CT technologies.
• Expanded use: Maintains a small footprint ideal for mobile use while increasing the gantry opening to 40 cm for improved coverage of adult head and neck, and full body pediatric scanning.
• Enhanced safety system: OmniTom^® features an internal drive system, making portability less strenuous, while also offering smart-sensing collision avoidance software to maximize control and patient safety.

OmniTom^® is ideal for cranial procedures and is designed to deliver the highest quality non-contrast CT, CT angiography and CT perfusion scans. The combination of its rapid scan time, ultra-small footprint and immediate image viewing makes OmniTom^® an indispensable tool for collecting real-time data on critically ill patients.

The latest product also demonstrates Samsung’s “AccE” (Access, Accuracy and Efficiency) strategy that aims to change the industry by incorporating innovations in physical access to provide care wherever it is needed. It also aims to improve accuracy in diagnosis with advanced algorithms and efficiency with advanced display, UX and information management technology developed by Samsung Electronics.

“OmniTom^® embodies Samsung’s commitment to providing leading technologies to healthcare providers by combining our key values of Access, Accuracy and Efficiency,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “We’ve made a CT product that’s lighter, more mobile, more accurate and faster, and we hope the many doctors and technicians here at RSNA will be able to use it to benefit their patients.”

“At Samsung, we work tirelessly to make sure that our full range of products provide patients and physicians with the best possible options for care” added Philip Sullivan, President and CEO Samsung NeuroLogica. “We do this through designing products that deliver broad access, superior accuracy and quality, and make care teams more efficient by maximizing throughput and minimizing waste.”

In addition to OmniTom^®, Samsung will be showcasing its spectral CT with Photon Counting Detector (PCD), the next generation of CT technology. Samsung’s team will also be demonstrating a range of healthcare solutions in mobile CT, Digital Radiography and Ultrasound that are all designed to bridge the care-delivery gap and maximize efficiency to enhance the patient experience. Such solutions include:

• Ultrasound Segment: Samsung will feature their comprehensive general imaging ultrasound portfolio, including the new HS60 and HS40 ultrasound systems which were introduced earlier this year. The RS80A with Prestige, Samsung’s premium general imaging ultrasound system, will be displayed in three daily educational demonstrations featuring live scanning. The RS80A includes innovative technologies for the busy radiology department that help boost clinical confidence. Based on its achievements in ultrasonic diagnosis devices for obstetrics and gynecology, the company is strengthening its premium ultrasonic diagnosis device business for radiology, which has the biggest market potential.

• Digital Radiography Segment: Samsung will display a wide range of its portfolio including two ceiling-mounted systems, GC85 and GC70, as well as highlight its premium portable GM85 X-ray. The GM85’s enhanced mobility and streamlined workflow will enable users to experience a new level of efficiency along with exceptional image quality. Samsung has also differentiated itself from its competitors by adopting low dose technology for enhanced patient safety.

• Magnetic Resonance Imaging Segment: Samsung will be showcasing a prototype of Specialty MRI, an MRI imaging device for arms and/or legs. The prototype is expected to be a game changer in the industry: It is designed to maximize not only cost and space but also patient convenience, as it eliminates the need for the whole body to be in the MRI device.

Learn more by visiting Samsung at booth #2543 (South Building, Hall A) at the RSNA 2017 Annual Meeting, as well as following Samsung NeuroLogica on Facebook, Twitter and LinkedIn.

About Samsung NeuroLogica

Samsung NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures and markets innovative imaging technologies, and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Samsung NeuroLogica, the global corporate headquarters and manufacturer of Samsung computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Samsung NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. Samsung is committed to being leaders in the field of healthcare imaging. For more information, please visit www.SamsungNeuroLogica.com.

UOG is the official journal published by the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). The image that the publication selected represents a breakthrough for Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics. Its fetal echocardiography technology called 5D Heart Color allows a precise diagnosis of congenital heart disease.

The clinical image was obtained from a 26-week fetus with hypoplastic left heart and coarctation of the aorta, in which nine standard fetal echocardiography views with automatic labeling were displayed on a single screen.

The story behind the image can be found in a research paper led by Prof. Roberto Romero, Chief of the Perinatology Research Branch of the National Institute of Child Health and Human Development (NICHD)/National Institutes of Health in the U.S., and Prof. Lami Yeo, M.D., from the Department of Obstetrics and Gynecology at the Wayne State University School of Medicine in Detroit, U.S.

According to the research, the Picture of the Month illustrates how the cardiac diagnostic planes shown by 5D Heart Color (i.e. color Doppler FINE – Fetal Intelligent Navigation Echocardiography) allowed a precise diagnosis of hypoplastic left heart with coarctation of the aorta, and that such planes demonstrated evidence of abnormal fetal cardiac anatomy and hemodynamic flow.

The publication stated, “The characteristic features of this congenital heart defect were visualized in the seven echocardiography views. In the four-chamber view, the left side of the heart was severely hypoplastic with absent flow through the atretic mitral valve, and the aortic arch view showed a very narrow transverse aortic arch (coarctation) with reversed color Doppler flow in this area and the isthmus.”

Samsung’s 5D Heart Color provides nine different fetal echocardiography views containing clinically useful information about cardiac structure and function, including the three vessels and trachea view, four-chamber view, left and right ventricular outflow tract views, aortic arch view, and four others. In cases of congenital heart disease, since abnormal fetal cardiac anatomy and hemodynamic flow characteristics are depicted, this enhances the diagnostic potential of the technology. In addition, there is reduced operator dependency, and examination of the fetal heart is standardized and simplified.

As 5D Heart Color marks the second time Samsung Medison’s technology has been selected as Picture of the Month, (The company’s Crystal Vue also gained the honor in 2016) it’s an illustration of how Samsung Medison is continuing to establish its brand power in the global women’s health industry by providing technology with clinical value to medical professionals.

“It is exciting to see 5D Heart Color is being featured on the front cover of UOG, especially since the diagnostic accuracy of 5D Heart was presented at last month’s World Congress on Ultrasound in Obstetrics and Gynecology,” said Insuk Song, Vice President of the Health & Medical Equipment of Samsung Electronics. “Samsung will continue to focus on developing medical technology that can improve the detection of fetal congenital heart disease and contribute to saving more lives.”

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, is hosting a number of seminars at the 27th World Congress of the International Society of Ultrasound in Obstetrics & Gynecology (ISUOG) in Vienna. Through 13 sessions at Samsung’s Satellite Symposium, leading medical professionals are publicizing the clinical benefits of Samsung’s ultrasound imaging solutions for women’s health.

Professor Lami Yeo, M.D., from the Department of Obstetrics and Gynecology at the Wayne State University School of Medicine in Detroit, U.S., presented research on the diagnostic performance of Fetal Intelligent Navigation Echocardiography (5D Heart) which showed a sensitivity of 98%, specificity of 93%, and accuracy of 95% for the prenatal detection of congenital heart disease*.  She also explained that 5D Heart offers a rapid and simple solution to screen for and diagnose congenital heart disease by generating nine standard fetal echocardiography views in a single template display.

Additionally, novel research conducted on color Doppler Fetal Intelligent Navigation Echocardiography (5D Heart Color) will be published in the October 2017 issue of the scientific journal Ultrasound in Obstetrics & Gynecology (UOG), which will also feature on its front cover, the prenatal diagnosis of congenital heart disease using 5D Heart color.

In addition recently developed diagnostic tools such as E-Cervix, Crystal Vue and IOTA-ADNEX from Samsung’s Crystal Clear Cycle, the lifelong healthcare solution for women, are also being presented throughout the congress.

Samsung also displayed prototypes of ultrasound system with new ergonomics and stress-relief transducers, as well as cloud-based IT solution at a private room for selectively invited key opinion leaders. Visitors to the room shared feedbacks that the next-generation product meets the needs of professionals and patients with a form that is entirely unlike the norm. Some also showed positive response to the new IT solution designed to provide efficiency for doctor’s demanding tasks, and that they look forward to its commercial release.

“I believe Samsung’s proactive technological developments in ultrasound in recent years are providing quite significant clinical value to the field. Samsung has been releasing machines for users at all levels of expertise,” said Dr. Andrew Ngu, former President of the ISUOG. “Seeing Samsung’s vision for design innovations that enhance user workflow and efficiency, it is not difficult to expect Samsung to play a pivotal role as a game changer for the future ahead.”

For additional information, [click here].

* Congenital heart disease is the most common organ-specific birth defect, and is also the leading cause of infant mortality from congenital malformations. The performance of conventional two-dimensional ultrasound of the fetal heart is time-consuming, requires considerable expertise and skill, and therefore is highly operator dependent. As a result, not all fetal cardiac views required for the accurate prenatal detection of congenital heart disease may be routinely obtained.

Samsung’s WS80A with Crystal Vue technology.

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, announced that its latest imaging technology ‘Crystal Vue’ has been featured on the front cover of Ultrasound in Obstetrics & Gynecology (UOG), a renowned academic journal in the women’s healthcare industry and the official journal published by the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG).

The March edition of the UOG featured a clinical case study by Dr. Christoph Lees, professor at the Department of Surgery & Cancer within the Faculty of Medicine at Imperial College in London. Using Samsung’s premium diagnostic ultrasound system WS80A, professor Lees introduced two cases of prenatal imaging through Crystal Vue, of which the rib & vertebral images were selected as the Picture of the Month by UOG.

“Our experience with Crystal Vue over the past few months, specifically imaging of the bone and soft tissue interface, leads us to believe that it may offer new opportunities for prenatal imaging, particularly for the skeletal system, but also in facial and brain imaging,” Professor Lees stated in his study. “We were able to obtain highly detailed images that give particular information on the contour of the ribs and allow inference on mineralization.”

Crystal Vue is an advanced 3D volume rendering technology that enables users to assess detailed information of internal and external structures of the fetus or uterus and helps easily differentiate between the soft tissue and bone. With the additional morphological information, users may deepen their understanding of the patients and fetus.

Crystal Vue was first introduced at the 25th World Congress on Ultrasound in Obstetrics and Gynecology, held in Canada in October 2015, as the latest imaging function of the WS80A. The WS80A with Crystal Vue is currently available globally.

“We are thrilled that Samsung’s latest technology was recognized in a leading academic journal as a new diagnostic imaging that can provide more clinical values in women’s health,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “With Samsung’s leading display and software technology, we will continue to develop new features that can increase diagnosis confidence and contribute to women and fetal health.”

The cover of the March issue of Ultrasound in Obstetrics & Gynecology.

To access the case study featured in the UOG, please visit,

http://onlinelibrary.wiley.com/doi/10.1002/uog.15800/full.

For detailed information on the Crystal Vue and WS80A, please visit,

http://www.samsungmedison.com/micro/WS80A_with_Elite/main.jsp.

To learn more about Samsung’s global medical equipment business, please visit,

http://www.samsung.com/global/business/healthcare/.

Visitors awaiting Samsung Electronics’ CT unveiling at the RSNA’s 101st annual meeting on November 28.

Samsung Electronics is strengthening its commitment to delivering fast, reliable, smart and innovative diagnostic solutions for healthcare providers by debuting the newest additions to its portfolio, on display at the Radiological Society of North America (RSNA) Annual Meeting at McCormick Place in Chicago. This week at booth #7313 (North Building, Hall B), product specialists will be on hand demonstrating Samsung’s range of solutions in Computed Tomography (CT), Ultrasound and Digital Radiography (DR) systems, which are all designed to enrich the quality of care and workflow, and enhance the patient experience.

“Through our innovative designs and advanced technologies, we remain committed to delivering new solutions, like the NExCT 7 and the RS80A with Prestige, that unlock workflow efficiencies for medical professionals as well as improve patients’ lives,” said Soo-In Cho, President and Head of the Health & Medical Equipment Business at Samsung Electronics Co., Ltd. “By leveraging the combination of Samsung imaging technology and user-inspired design, we will continue to deliver on our promise of fast, easy and accurate diagnostic solutions for our customers in the healthcare community.”

Wayne Spittle, Executive Vice President of Samsung Medison, introducing the NExCT 7, Samsung’s first CT scanner.

Computed Tomography (CT) Segment

Samsung’s CT imaging solutions are used throughout the world in intensive care units, neurosurgical operating rooms, emergency departments, stroke centers and other key clinical areas. Debuting at RSNA is:

• NExCT 7 – the first premium CT scanner from Samsung features high resolution designed to improve diagnostic confidence in advanced and routine exams reducing the radiation dose as low as reasonably achievable and ensuring a fast and efficient workflow. Some features of the NExCT7 are FDA 510(k) pending.

• Portable CT – Samsung will be showcasing the latest in software and hardware enhancements across its portable CT product line. These upgrades improve user satisfaction and streamline workflow, and both systems are now compliant with the Smart Dose (XR-29) radiation dose reporting standard.

The BodyTom and CereTom portable systems continue to prove their versatility as they are increasingly adopted and utilized in a wide range of market applications such as mobile stroke units, brachytherapy suites, proton therapy centers, deep brain stimulation and even veterinarian hospitals.

Ultrasound Segment

Samsung continues to enhance the user experience with its cutting-edge diagnostic ultrasound devices around the world and across various medical fields. On display at RSNA are:

• RS80A with Prestige – now available in the U.S. market, this system features advanced technical capabilities built on the successes of Samsung technologies. Product features include:

• S-Fusion to enable simultaneous localization of lesions with a real-time ultrasound image supported by other modalities’ 3D data sets. Fusion speed and accuracy are the strengths of S-Fusion.
• S-Shearwave to detect the velocity of the shearwave transmitted through the targeted lesion and display the numerical measurement of stiffness.
• E-Breast*: this is the function for breast lesion exam, which calculates the strain between the area of the suspected lesion (ROI) and normal breast fat and displays the results.
• E-Thyroid*: This function assists with the diagnosis of thyroid lesions. The ROI is used to show the contrast of an elastogram.*The strain ratio value is a relative value regarding quantification, not an absolute value.

• HS70A – designed for hospital and private care. This system has a flexible architecture to meet the clinical needs of varied users. The HS70A offers a complete Radiology and Cardiovascular solution, including technologies migrated from the premium radiology RS80A platform. Features include S-Detect, which uses Breast Imaging-Reporting, and Data System (BI-RADS®) scores for analysis and classification of suspicious lesions.

Digital Radiography (DR) Segment

Samsung’s DR systems combine advanced imaging technology, award-winning design and user-friendly automated workflows to meet the demands of 21st century radiology departments. Products on display at RSNA include:

• GC85A – a DR system offering streamlined workflow, diagnostic confidence and improved total cost of ownership. The GC85A features imaging engine S-Vue, ensuring consistency with high quality, convenient setting of contrast and improved sharpness and clarity, S-Share to support unique clinical needs and continuous care with increased connectivity, and Smart Control for one-touch precise positioning.
• GM60A – a mobile Digital Radiography system that delivers high-quality imaging directly to the patient’s bedside. Advanced mobility allows use in the patient room, emergency room, operating room and the intensive care unit, and has advanced features, including S-Detector and S-Vue imaging technologies to deliver accurate diagnoses while ensuring reliable operation with enhanced usability. Additionally, the telescopic column ensures fast navigation by securing a clear view for users.

For more information about Samsung’s showcase at RSNA, please visit http://www.samsung.com/rsna2015.

To learn more about Samsung’s healthcare work, please visit samsung.com/global/business/healthcare/.

About NeuroLogica

NeuroLogica, a healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of computed tomography, is also the U.S. headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. Samsung is committed to being leaders in the field of healthcare imaging. For more information, please visit www.SamsungNeuroLogica.com.